INSTITUT KLINICK A EXPERIMENTLN MEDICNY
A United Kingdom buyer, with 44 published contracts, worth £1.2bn, most recently 4 months ago.
Top 5 suppliers won 54% of awarded value — £171.2m of £315.9m across 32 awards.
This public procurement contract involves the supply of pharmaceutical products for parenteral administration containing the active ingredient risankizumab (ATC L04AC18). These products are intended for the treatment of patients in approved indications according to the Summary of Product Characteris
